Tag: Stocks

Airlines ETF & Stocks Ride the Rebound in Travel Demand

The coronavirus outbreak has hammered the U.S. economy, with the airline sector being one of the worst-hit spaces. The virus’ spread resulted in declining air travel with restrictions imposed by the government. Consequently, airlines’ top lines suffered a material impact as passenger revenues form the largest component of their total revenue base. However, it seems like the worst is over for the airline industry as the United States has started to reopen its economy with permission for inter-state travel.

In fact, airlines in many parts of the world are planning to resume flights starting this month as economies are reopening

Read more

FOMO Trading Driving The Rotation Towards Value Stocks

The stock market is continuing its unprecedented rally with the S&P 500 surging past the 3,000-point benchmark and the Dow Jones Industrial topping 25,000 for the first time since the beginning of March. Secular growth stocks had driven the last two months of the markets rally with the pandemic providing well-positioned tech companies with a rare tailwind. Now, investors are beginning to rotate towards cyclical and value names, which have yet to break out from the market’s initial crash.

Investors are starting to feel more optimistic about our economic condition as state economies begin opening, and another round of fiscal

Read more

Stocks rebound Monday as Moderna’s coronavirus vaccine trial boosts optimism for economy

Stocks rebounded Monday from losses last week on optimism that the U.S. economy might start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine. 

The Dow Jones industrial average soared 912 points to close at 24,597. The S&P 500 jumped 3.2%, erasing its losses from last week.

Shares of Moderna surged 20% after the biotechnology company reported encouraging phase one results for a potential COVID-19 vaccine in a small early stage clinical trial. It showed the production of antibodies to the virus in all of its 45 trial participants, Moderna said, a positive

Read more